CompaniesByCap
SPRO
Spero Therapeutics Inc. (SPRO)
NASDAQ · Healthcare

Spero Therapeutics Inc. Income Statement 2016–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenues
Revenue12.6M371,000933,0002.5M3.1M258,0004.7M4.0M2.0M335,000
Gross Profit
Profitability
Operating Income6.3M-73.4M21.5M-42.2M-88.0M-79.1M-63.2M-42.8M-41.7M-33.2M
EBITDA6.3M-73.4M21.8M-41.3M-87.3M-78.4M-62.5M-42.4M-41.4M-32.9M
Net Income8.6M-68.6M22.8M-89.8M-78.3M-60.9M-41.7M-38.7M-25.5M
Per Share Data
EPS (diluted)
Shares Outstanding (dil.)59M54M53M38M31M29M19M17M14M0M

Spero Therapeutics Inc. Income Statement — FAQ

Spero Therapeutics Inc. (SPRO) income statement over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see SPRO's income statement history?

The chart and table above show Spero Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.